cGMP favors the interaction between APP and BACE1 by inhibiting Rab5 GTPase activity

Francesca Caudano, Giulia Montalto, Mario Passalacqua, Maria A. Pronzato, Ernesto Fedele, Roberta Ricciarelli

Research output: Contribution to journalArticle

Abstract

We previously demonstrated that cyclic guanosine monophosphate (cGMP) stimulates amyloid precursor protein (APP) and beta-secretase (BACE1) approximation in neuronal endo-lysosomal compartments, thus boosting the production of amyloid-β (Aβ) peptides and enhancing synaptic plasticity and memory. Here, we further investigated the mechanism by which cGMP regulates the subcellular localization of APP and BACE1, finding that the cyclic nucleotide inhibits the activity of Rab5, a small GTPase associated with the plasma membrane and early endosomes. Accordingly, we also found that expression of a dominant-negative Rab5 mutant increases both APP-BACE1 approximation and Aβ extracellular levels, therefore mimicking the effects induced by cGMP. These results reveal a functional correlation between the cGMP/Aβ pathway and the activity of Rab5 that may contribute to the understanding of Alzheimer’s disease pathophysiology.

Original languageEnglish
Article number1358
JournalScientific Reports
Volume10
Issue number1
DOIs
Publication statusPublished - Dec 1 2020

    Fingerprint

ASJC Scopus subject areas

  • General

Cite this

Caudano, F., Montalto, G., Passalacqua, M., Pronzato, M. A., Fedele, E., & Ricciarelli, R. (2020). cGMP favors the interaction between APP and BACE1 by inhibiting Rab5 GTPase activity. Scientific Reports, 10(1), [1358]. https://doi.org/10.1038/s41598-020-58476-8